Deficiency of core fucosylation activates cellular signaling dependent on FLT3 expression in a Ba/F3 cell system

Abstract

Fms-like tyrosine kinase 3 (FLT3) is a glycoprotein, that is a member of the class III receptor tyrosine kinase family. Approximately one-third of acute myeloid leukemia (AML) patients have mutations of this gene, and activation of the FLT3 downstream pathway plays an important role in both normal and malignant hematopoiesis.However, the role of N-glycosylation for FLT3 activation remains unclear. In this study, we showed that the N-glycan structures on wild type (WT), internal tandem duplication (ITD), and tyrosine kinase domain (TKD) mutants of FLT3 were different. Interestingly, expression of either WT or mutant FLT3 in Ba/F3 cells, an interleukin-3 (IL-3)-dependent hematopoietic progenitor cell, greatly induced core fucosylation. To elucidate the function of core fucosylation in FLT3-mediated signaling, we used a CRISPR/Cas9 system to establish α1,6-fucosyltransferase (Fut8) knockout (KO) cells. Surprisingly, the Fut8KO resulted in cell proliferation in an IL-3-independent manner in FLT3-WT cells, which was not observed in the parental cells, and suggested that this proliferation is dependent on FLT3 expression. Fut8KO greatly increased cellular tyrosine phosphorylation levels, together with an activation of STAT5, AKT, and ERK signaling, which could be completely neutralized by restoration with Fut8 in the KO cells. Consistently, a tyrosine kinase inhibitor efficiently inhibited cell proliferation induced by Fut8KO or specific fucosylation inhibitor. Additionally, immunostaining with FLT3 showed that the proteins were mainly expressed on the cell surface in the KO cells, which is similar to FLT3-WT cells, but different from the ITD mutant. Finally, we found that Fut8KO could induce dimer-formation in FLT3 without ligand-stimulation. Taken together, the present study clearly defines the regulatory function of core fucosylation in FLT3, which could provide a valuable direction for development of drugs could be effective in the treatment of AML. K E Y W O R D Sacute myeloid leukemia, cellular signaling, core fucosylation, FLT3, Fut8 3240 |

Expression of GnT-III decreases chemoresistance via negatively regulating P-glycoprotein expression: Involvement of the TNFR2-NF-κB signaling pathway

“…A cross-linking assay was performed as described previously ( 72 ). Briefly, cells were centrifuged and resuspended in culture medium incubated with or without human recombinant TNFα (5 ng/ml) for 5 min at 37 °C.…”

Set Protein Is Involved in FLT3 Membrane Trafficking

“…It is well known that glycosylation is a necessary step for the plasma membrane location of FLT3 [ 21 , 22 ]. Recent studies hint that glycosylation differs in the WT- and ITD-FLT3 proteins [ 29 , 30 ]; however, our results suggest a more complex scenario since SET/FLT3 binding is prior to glycosylation. However, FLT3-SET-RAC1 binding is not sufficient for correct membrane transport because glycosylation inhibition impaired FLT3 membrane transport.…”

BRCC36 associates with FLT3‐ITD to regulate its protein stability and intracellular signaling in acute myeloid leukemia

“…ITD and TKD can induce a robust activation of STAT5. The Ba/F3 cell was an interleukin‐3 (IL‐3)‐dependent cell line and IL‐3 can induce STAT5 phosphorylation in FLT3‐WT Ba/F3 cells 30 . We found that the Golgi entry was essential for mutant‐mediated cellular signaling.…”